Abbott India Ltd

Abbott India Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Abbott India Ltd

₹ 34,125 -0.12%
18 Jul - close price
abbott.co.in BSE: 500488 NSE: ABBOTINDIA
About

Abbott India Ltd is one of the leading multinational pharmaceutical companies in India and sells its products through independent distributors primarily within India.[1] It was established in 1944.[2]

Key Points

Abbott Group
The company is a part of Abbott Laboratories, USA which has a presence in 160 countries with leading medical devices, diagnostics, nutrition products, and branded generic medicines. [1]

Website BSE NSE
  • Market Cap ₹ 72,516 Cr.
  • Current Price ₹ 34,125
  • High / Low ₹ 37,000 / 25,260
  • Stock P/E 51.3
  • Book Value ₹ 1,992
  • Dividend Yield 1.39 %
  • ROCE 46.2 %
  • ROE 35.7 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Company has delivered good profit growth of 19.0% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 34.2%
  • Company has been maintaining a healthy dividend payout of 72.2%

Cons

  • Stock is trading at 17.1 times its book value
  • The company has delivered a poor sales growth of 9.38% over past five years.
  • Working capital days have increased from 28.1 days to 101 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Part of BSE 500 BSE Healthcare BSE 200 Nifty 500 BSE MidCap

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
1,255 1,304 1,379 1,322 1,343 1,479 1,494 1,437 1,439 1,558 1,633 1,614 1,605
961 1,034 1,036 1,010 1,063 1,124 1,113 1,049 1,109 1,167 1,194 1,178 1,176
Operating Profit 294 270 343 312 280 355 381 388 330 391 439 436 429
OPM % 23% 21% 25% 24% 21% 24% 25% 27% 23% 25% 27% 27% 27%
21 27 34 44 50 56 56 56 81 67 60 72 76
Interest 5 4 4 4 4 3 3 3 3 3 2 2 4
Depreciation 17 17 17 18 17 17 18 18 18 18 18 18 18
Profit before tax 292 275 355 335 308 390 415 422 390 437 479 488 483
Tax % 28% 25% 25% 26% 25% 26% 25% 26% 26% 25% 25% 26% 24%
211 206 266 247 231 290 313 311 287 328 359 361 367
EPS in Rs 99.49 96.77 124.95 116.16 108.91 136.59 147.27 146.35 135.09 154.36 168.76 169.78 172.73
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2014 15m Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
2,276 2,289 2,614 2,903 3,298 3,679 4,093 4,310 4,913 5,349 5,849 6,409
2,009 1,977 2,250 2,505 2,774 3,074 3,336 3,388 3,832 4,143 4,396 4,715
Operating Profit 267 312 365 398 525 605 757 922 1,082 1,206 1,453 1,695
OPM % 12% 14% 14% 14% 16% 16% 18% 21% 22% 23% 25% 26%
49 48 50 57 117 113 114 81 83 154 248 276
Interest 0 0 3 2 4 2 9 18 19 16 12 11
Depreciation 22 15 14 16 16 17 60 58 66 70 71 72
Profit before tax 295 344 398 436 621 699 803 926 1,080 1,274 1,618 1,887
Tax % 33% 34% 36% 37% 35% 36% 26% 25% 26% 25% 26% 25%
198 229 255 277 401 450 593 691 799 949 1,201 1,414
EPS in Rs 93.39 107.75 120.12 130.19 188.82 211.93 279.04 325.04 375.87 446.80 565.30 665.64
Dividend Payout % 25% 29% 29% 31% 29% 31% 90% 85% 73% 73% 73% 71%
Compounded Sales Growth
10 Years: 11%
5 Years: 9%
3 Years: 9%
TTM: 10%
Compounded Profit Growth
10 Years: 20%
5 Years: 19%
3 Years: 21%
TTM: 18%
Stock Price CAGR
10 Years: 23%
5 Years: 18%
3 Years: 19%
1 Year: 25%
Return on Equity
10 Years: 30%
5 Years: 32%
3 Years: 34%
Last Year: 36%

Balance Sheet

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 21 21 21 21 21 21 21 21 21 21 21 21
Reserves 767 916 1,174 1,366 1,672 1,987 2,410 2,581 2,799 3,167 3,678 4,212
0 0 0 0 0 0 175 153 152 113 83 197
351 436 421 679 723 932 940 1,086 1,253 1,254 1,411 1,487
Total Liabilities 1,139 1,374 1,616 2,066 2,416 2,941 3,547 3,840 4,224 4,556 5,193 5,917
98 96 108 110 81 105 270 251 271 237 225 336
CWIP 1 4 3 6 2 1 2 1 1 4 10 18
Investments 0 0 0 0 0 0 0 0 0 0 0 0
1,040 1,274 1,505 1,950 2,333 2,835 3,275 3,589 3,952 4,315 4,958 5,563
Total Assets 1,139 1,374 1,616 2,066 2,416 2,941 3,547 3,840 4,224 4,556 5,193 5,917

Cash Flows

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
155 215 249 307 153 499 626 727 948 893 1,213 1,012
-144 -187 -77 -155 -215 -257 -401 -72 -396 -148 -416 182
-42 -58 -80 -90 -102 -143 -217 -582 -637 -639 -745 -925
Net Cash Flow -31 -30 91 62 -165 99 8 73 -86 107 52 269

Ratios

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 18 21 20 22 29 27 28 21 21 22 20 22
Inventory Days 101 107 91 107 112 106 83 110 94 80 70 92
Days Payable 38 54 56 101 92 116 104 116 122 109 114 110
Cash Conversion Cycle 80 74 54 28 49 17 8 14 -6 -8 -24 3
Working Capital Days 36 30 32 21 63 22 14 7 -4 -5 -12 101
ROCE % 39% 40% 38% 34% 41% 37% 35% 35% 38% 41% 46% 46%

Shareholding Pattern

Numbers in percentages

Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025
74.99% 74.99% 74.99% 74.99% 74.99% 74.99% 74.99% 74.99% 74.99% 74.99% 74.99% 74.99%
0.20% 0.20% 0.19% 0.19% 0.19% 0.18% 0.18% 0.18% 0.17% 0.17% 0.16% 0.16%
7.85% 8.38% 8.61% 8.77% 8.83% 8.73% 8.91% 8.81% 9.00% 9.01% 8.91% 9.18%
16.95% 16.42% 16.20% 16.05% 16.01% 16.09% 15.92% 16.01% 15.86% 15.85% 15.94% 15.67%
No. of Shareholders 83,52674,91572,08669,58268,88572,25269,38271,58869,44967,89269,93467,584

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Concalls